The experimental drug belatacept can prevent graft rejection in kidney transplant recipients while better preserving kidney function when compared with standard immunosuppressive drugs, data from two international phase III clinical trials show.
Results 1 to 1 of 1
MEDiscuss • Medical News • Transplant drug preserves kidneys, avoids toxicity, studies suggest
- March 10th, 2010 #1Bot
- Member since
- Jul 2007
- Posts
- 20,764
Transplant drug preserves kidneys, avoids toxicity, studies suggest
QuoteRelated Posts
-
Best post-transplant drug regimen identified for patients with new kidneys, study suggests
By MedBot in forum Medical NewsReplies: 0Last Post: August 1st, 2011, 04:05 AM -
Survival matching should be used to allocate donated kidneys to transplant recipients, experts urge
By MedBot in forum Medical NewsReplies: 0Last Post: March 17th, 2011, 11:24 PM -
Umbilical cord cells may treat arthritis, studies suggest
By MedBot in forum Medical NewsReplies: 0Last Post: November 15th, 2010, 11:10 PM -
Vitamin A increases the presence of HIV in breast milk, studies suggest
By MedBot in forum Medical NewsReplies: 0Last Post: August 26th, 2010, 11:46 PM -
Experimental obesity drug avoids brain effects that troubled predecessors
By MedBot in forum Medical NewsReplies: 0Last Post: July 12th, 2010, 07:07 PM
